EUR/USD likely to find a peak near 1.25: UBS
Investing.com - Rockwell Medical reported on Monday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Rockwell Medical announced earnings per share of $-0.4000 on revenue of $18.7M. Analysts polled by Investing.com EPS of $-0.4850 on revenue of $19.37M.
Rockwell Medical 's are down 89% and is trading at $1.1660 , still down 83.69% from its 52 week high of $7.15 set on Thursday, January 13, 2022.
Rockwell Medical shares gained 13.20% to trade at $1.1660 in intra-day trade the report.
Rockwell Medical follows other major Healthcare sector earnings this month
Rockwell Medical's report follows an earnings beat by J&J on Tuesday, October 18, 2022, who reported EPS of $2.55 on revenue of $23.79B, EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.98 on revenue of $6.94B, for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar